Nuveen Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $388K | Sell |
23,053
-92,110
| -80% | -$1.55M | ﹤0.01% | 3068 |
|
|
2024
Q3 | $1.86M | Buy |
+115,163
| New | +$1.86M | ﹤0.01% | 2447 |
|
|
2024
Q2 | – | Sell |
-322,335
| Closed | -$4.77M | – | 3401 |
|
|
2024
Q1 | $4.77M | Buy |
322,335
+75,668
| +31% | +$1.12M | ﹤0.01% | 2021 |
|
|
2023
Q4 | $3.58M | Buy |
246,667
+664
| +0.3% | +$9.63K | ﹤0.01% | 2127 |
|
|
2023
Q3 | $2.66M | Buy |
246,003
+275
| +0.1% | +$2.97K | ﹤0.01% | 2175 |
|
|
2023
Q2 | $3.17M | Sell |
245,728
-29,284
| -11% | -$378K | ﹤0.01% | 2129 |
|
|
2023
Q1 | $3.63M | Buy |
275,012
+3,386
| +1% | +$44.7K | ﹤0.01% | 2057 |
|
|
2022
Q4 | $4.08M | Buy |
271,626
+45,879
| +20% | +$688K | ﹤0.01% | 2027 |
|
|
2022
Q3 | $2.66M | Sell |
225,747
-83,817
| -27% | -$989K | ﹤0.01% | 2251 |
|
|
2022
Q2 | $3.5M | Sell |
309,564
-105,080
| -25% | -$1.19M | ﹤0.01% | 2159 |
|
|
2022
Q1 | $13.4M | Sell |
414,644
-36,324
| -8% | -$1.17M | ﹤0.01% | 1456 |
|
|
2021
Q4 | $12M | Buy |
450,968
+45,150
| +11% | +$1.2M | ﹤0.01% | 1587 |
|
|
2021
Q3 | $14.7M | Sell |
405,818
-10,885
| -3% | -$395K | ﹤0.01% | 1495 |
|
|
2021
Q2 | $18.1M | Buy |
416,703
+86,923
| +26% | +$3.77M | 0.01% | 1448 |
|
|
2021
Q1 | $11.3M | Buy |
329,780
+253,839
| +334% | +$8.68M | ﹤0.01% | 1726 |
|
|
2020
Q4 | $2.66M | Sell |
75,941
-2,157
| -3% | -$75.5K | ﹤0.01% | 2363 |
|
|
2020
Q3 | $1.87M | Buy |
78,098
+1,765
| +2% | +$42.4K | ﹤0.01% | 2417 |
|
|
2020
Q2 | $1.4M | Buy |
76,333
+16,059
| +27% | +$294K | ﹤0.01% | 2480 |
|
|
2020
Q1 | $941K | Sell |
60,274
-1,966
| -3% | -$30.7K | ﹤0.01% | 2535 |
|
|
2019
Q4 | $1.33M | Hold |
62,240
| – | – | ﹤0.01% | 2585 |
|
|
2019
Q3 | $1.16M | Sell |
62,240
-3,716
| -6% | -$69.5K | ﹤0.01% | 2633 |
|
|
2019
Q2 | $1.72M | Buy |
+65,956
| New | +$1.72M | ﹤0.01% | 2503 |
|